MD Anderson and RaySearch announce strategic alliance to advance radiation therapy of cancer
Share

HOUSTON – The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives, including more precisely targeting of tumors, and improving upon, and making more available, an existing radiation therapy called adaptive radiation therapy (ART), which is currently only used at highly specialized care centers.

Successful radiation therapy depends on the ability to delineate the precise tumor location. Since most radiation treatments are delivered over several weeks, a number of variables can compromise treatment accuracy. Traditionally, additional margins are set around the target area to allow for tumor movement and variations in how patients are positioned during treatment.

However, these margins do not always compensate for unexpected changes in the tumor and surrounding normal tissue over the full course of radiation treatment. ART uses frequent imaging to give an up-to-date assessment of physical changes and enable precisely tailored treatment for each patient.

The alliance builds upon a previously established relationship between RaySearch and MD Anderson centered on RayCare®, RaySearch’s new oncology information system. This new collaboration combines MD Anderson’s clinical data and expertise with the latest technology and platforms available through RaySearch and

read more...


Article originally posted at
www.eurekalert.org

Click here for the full story


CategoryAggregator News

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD